HRSA launches voluntary 340B rebate model while CMS codifies drug price negotiation rules affecting pharmaceutical manufacturers
Lisa Henderson is a Deputy News Editor at various prominent publications. She focuses on themes related to medicine and healthcare, healthcare technology, supply chain and logistics, as well as legal affairs, exploring topics such as healthcare administration, patient care, and digital health innovations. Lisa's work has been featured in Pharmaceutical Executive, Applied Clinical Trials Magazine, BioRxiv, GeoComm, IQ Magazine, Policy Exchange, Worthing Herald, and ALLEN.